World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
129
Citations
57563
World Ranking
247
National Ranking
23

Medicine

D-Index
129
Citations
57563
World Ranking
2617
National Ranking
269

Research.com Recognitions

  • 1997 - Fellow of the Royal Society, United Kingdom

Overview

Alan B. Rickinson is affiliated with the University of Birmingham in the United Kingdom. Their research primarily focuses on the field of Medicine, with significant contributions to Oncology, Immunology, Pathology and Forensic Medicine, and Epidemiology. The scientist's work spans multiple topics including Multiple Sclerosis Research Studies, Immune Cell Function and Interaction, Viral-associated cancers and disorders, Polyomavirus and related diseases, T-cell and B-cell Immunology, and Cytomegalovirus and herpesvirus research.

Rickinson has coauthored research with several frequent collaborators including Olivia Thomas, Umaimainthan Palendira, Tracey A. Haigh, Deborah Croom-Carter, and Alison M. Leese. The common publication venues for their work include Clinical & Translational Immunology, PLoS Pathogens, Nature, UNC Libraries, and Proceedings of the National Academy of Sciences.

Recent papers authored or coauthored by Rickinson include:

  • "Anthony Epstein (1921-2024), discoverer of virus causing cancer in humans," 2024, Nature
  • "Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis," 2024, PLoS Pathogens
  • "Epstein-Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism," 2023, Clinical & Translational Immunology
  • "Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma," 2020, UNC Libraries
  • "Elliott Dan Kieff (1943 to 2024): Epstein-Barr virus cancer biology pioneer," 2024, Proceedings of the National Academy of Sciences

Rickinson was awarded the Fellowship of the Royal Society in the United Kingdom in 1997.

Best Publications

  • Epstein-Barr Virus

    Alan Rickinson

  • Epstein–Barr virus: 40 years on

    Lawrence S. Young;Alan B. Rickinson

  • Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.

    Sheila Henderson;Martin Rowe;Chris Gregory;Debbie Croom-Carter

  • HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION

    Alan B. Rickinson;Denis J. Moss

  • Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo

    M.F.C. Callan;L. Tan;N. Annels;G.S. Ogg

  • Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

    Andrew D Hislop;Graham S Taylor;Delphine Sauce;Alan B Rickinson

  • Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

    Roland Schmitz;Ryan M. Young;Michele Ceribelli;Sameer Jhavar

  • Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.

    L Young;C Alfieri;K Hennessy;H Evans

  • Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

    M Rowe;D T Rowe;C D Gregory;L S Young

  • Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.

    F Wang;C Gregory;C Sample;M Rowe

  • Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death

    Sheila Henderson;David Huen;Martin Rowe;Chris Dawson

  • Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

    R J Murray;M G Kurilla;J M Brooks;W A Thomas

  • The immunology of Epstein-Barr virus-induced disease.

    Unknown

  • ACTIVATION OF EPSTEIN-BARR VIRUS LATENT GENES PROTECTS HUMAN B CELLS FROM DEATH BY APOPTOSIS

    Christopher D. Gregory;Caroline Dive;Sheila Henderson;Christopher A. Smith

  • Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.

    L Brooks;Q Y Yao;A B Rickinson;L S Young

  • Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.

    R J Tierney;N Steven;L S Young;A B Rickinson

  • A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers

    Linda C. Tan;Nancy Gudgeon;Nicola E. Annels;Pokrath Hansasuta

  • Large clonal expansions of CD8 + T cells in acute infectious mononucleosis

    Margaret F.C. Callan;Neil Steven;Pete Krausa;Jamie D.K. Wilson

  • Epstein-Barr virus gene expression in nasopharyngeal carcinoma.

    L. S. Young;C. W. Dawson;D. Clark;H. Rupani

  • Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.

    D Wang;D Liebowitz;F Wang;C Gregory

  • Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

    F Wang;C D Gregory;M Rowe;A B Rickinson

Frequent Co-Authors

Andrew I. Bell
Andrew I. Bell University of Birmingham
Martin Rowe
Martin Rowe University of Birmingham
Lawrence S. Young
Lawrence S. Young University of Warwick
Christopher D. Gregory
Christopher D. Gregory University of Edinburgh
Paul Moss
Paul Moss University of Birmingham
Anthony T.C. Chan
Anthony T.C. Chan Chinese University of Hong Kong
Elliott Kieff
Elliott Kieff Harvard University
Denis J. Moss
Denis J. Moss QIMR Berghofer Medical Research Institute
Gerald Niedobitek
Gerald Niedobitek University of Erlangen-Nuremberg
Cliona M. Rooney
Cliona M. Rooney Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens the door to various specialized healthcare and research careers. For those interested in advancing clinical roles, exploring the cheapest psychiatric nurse practitioner programs can be a cost-effective way to enter mental health nursing, complementing immunological knowledge with psychiatric care skills.

Understanding salary expectations is crucial when planning your career. The dnp salary by specialty provides valuable insights into how different specializations within nursing, including immunology-related fields, can impact earning potential across states.

For nurses aiming to shift focus, the fnp to acnp bridge program online offers an efficient pathway from family nurse practitioner roles into acute care specialties, supporting career growth with flexible online options that blend immunological expertise and critical care.

Additionally, accelerated programs are available for those wishing to fast-track their credentials. The accelerated np program selection highlights top options to quickly advance in nurse practitioner roles, making it easier to integrate immunology into clinical practice sooner.

Best Scientists Citing Alan B. Rickinson

Trending Scientists

Recently Published Articles